Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone and Misoprostol vs Misoprostol in Early Pregnancy Loss
NCT05124314Phase 4Unknown
- Sponsor
- Clinical Hospital Merkur
- Start
- Oct 2021
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mifepristone in missed abortion (2 arms), sponsored by Clinical Hospital Merkur. Primary endpoint: Number of participants with complete evacuation of uterus at 3 weeks. Status: unknown.
02
Drugs
mifepristone
03
Conditions
missed abortion
Beyond the preview
Go deeper on NCT05124314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05124314.